Philip D. Mosier

3.1k citations

48 papers · 2.0k indexed · 1 hit paper · h-index 23

Molecular Biology top 5%
Cellular and Molecular Neuroscience top 2%
Organic Chemistry top 10%
Cell Biology top 5%
Computational Theory and Mathematics top 2%

Co-authors: Bryan L. Roth Umesh R. Desai Richard B. Westkaemper Eyal Vardy Raymond C. Stevens Vsevolod Katritch Huixian Wu Aaron A. Thompson
Topics: Receptor Mechanisms and Signaling (19 papers)Neuropeptides and Animal Physiology (13 papers)Pharmacological Receptor Mechanisms and Effects (11 papers)
Cited by: Cellular and Molecular Neuroscience Molecular Biology Cell Biology
Journals: Nature Journal of Biological Chemistry Angewandte Chemie International Edition
Partner nations: United States China Italy

In The Last Decade

Philip D. Mosier

48 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the human κ-opioid receptor in complex with JDTic

2012 718 citations Huixian Wu, Daniel Wacker et al. Nature profile →

Peers

Countries citing papers authored by Philip D. Mosier

Since Specialization

Citations

This map shows the geographic impact of Philip D. Mosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip D. Mosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip D. Mosier more than expected).

Fields of papers citing papers by Philip D. Mosier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip D. Mosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip D. Mosier. The network helps show where Philip D. Mosier may publish in the future.

Co-authorship network of co-authors of Philip D. Mosier

This figure shows the co-authorship network connecting the top 25 collaborators of Philip D. Mosier. A scholar is included among the top collaborators of Philip D. Mosier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philip D. Mosier. Philip D. Mosier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of novel phenoxyalkylpiperidines as high-affinity Sigma-1 (σ1) receptor ligands with potent anti-amnesic effect 2021 ·European Journal of Medicinal Chemistry ·(unknown),Philip D. Mosier,Mauro Niso,Leonardo Brunetti,Francesco Berardi,Fulvio Loiodice,Marialessandra Contino,Benjamin Delprat,Tangui Maurice,Antonio Laghezza,Carmen Abate	3
2	A Hexasaccharide Containing Rare 2‐O‐Sulfate‐Glucuronic Acid Residues Selectively Activates Heparin Cofactor II 2017 ·Angewandte Chemie International Edition ·Nehru Viji Sankaranarayanan,(unknown),(unknown),(unknown),Arjun Raghuraman,Florence Sallas,Philip D. Mosier,(unknown),Stefan Oscarson,Umesh R. Desai	53
3	Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1 2016 ·Scientific Reports ·Philip D. Mosier,(unknown),Zhengshi Lin,Yamei Gao,(unknown),Qibing Zhou,Faik N. Musayev,Martin K. Safo,Hang Xie,Umesh R. Desai	12
4	Single Amino Acid Variation Underlies Species-Specific Sensitivity to Amphibian Skin-Derived Opioid-like Peptides 2015 ·Chemistry & Biology ·Eyal Vardy,Maria F. Sassano,Andrew J. Rennekamp,Wesley K. Kroeze,Philip D. Mosier,Richard B. Westkaemper,(unknown),Vsevolod Katritch,Raymond C. Stevens,Randall T. Peterson,Bryan L. Roth	11
5	Designing “High-Affinity, High-Specificity” Glycosaminoglycan Sequences Through Computerized Modeling 2014 ·Methods in molecular biology ·Nehru Viji Sankaranarayanan,Aurijit Sarkar,Umesh R. Desai,Philip D. Mosier	19
6	Binding mode characterization of 6α- and 6β-N-heterocyclic substituted naltrexamine derivatives via docking in opioid receptor crystal structures and site-directed mutagenesis studies: Application of the ‘message–address’ concept in development of mu opioid receptor selective antagonists 2013 ·Bioorganic & Medicinal Chemistry ·Saheem A. Zaidi,Christopher K. Arnatt,Hengjun He,Dana E. Selley,Philip D. Mosier,Glen E. Kellogg,Yan Zhang	21
7	Chemotype-selective Modes of Action of κ-Opioid Receptor Agonists 2013 ·Journal of Biological Chemistry ·Eyal Vardy,Philip D. Mosier,Kevin J. Frankowski,Huixian Wu,Vsevolod Katritch,Richard B. Westkaemper,Jeffrey Aubé,Raymond C. Stevens,Bryan L. Roth	54
8	Designing Allosteric Regulators of Thrombin. Monosulfated Benzofuran Dimers Selectively Interact With Arg173 of Exosite 2 to Induce Inhibition 2012 ·Journal of Medicinal Chemistry ·May H. Abdel Aziz,Preetpal S. Sidhu,Aiye Liang,Ji Yeong Kim,Philip D. Mosier,Qibing Zhou,David H. Farrell,Umesh R. Desai	36
9	On scaffold hopping: Challenges in the discovery of sulfated small molecules as mimetics of glycosaminoglycans 2012 ·Bioorganic & Medicinal Chemistry Letters ·Preetpal S. Sidhu,Philip D. Mosier,Qibing Zhou,Umesh R. Desai	16
10	Structure of the human κ-opioid receptor in complex with JDTicbreakdown → 2012 ·Nature ·Huixian Wu,Daniel Wacker,Mauro Mileni,Vsevolod Katritch,Gye Won Han,Eyal Vardy,Wei Liu,Aaron A. Thompson,Xi‐Ping Huang,F. Ivy Carroll,S. Wayne Mascarella,Richard B. Westkaemper,Philip D. Mosier,Bryan L. Roth,Vadim Cherezov,Raymond C. Stevens	718
11	On the Specificity of Heparin/Heparan Sulfate Binding to Proteins. Anion-Binding Sites on Antithrombin and Thrombin Are Fundamentally Different 2012 ·PLoS ONE ·Philip D. Mosier,(unknown),Glen E. Kellogg,Umesh R. Desai	50
12	Identification of the site of binding of sulfated, low molecular weight lignins on thrombin 2011 ·Biochemical and Biophysical Research Communications ·May H. Abdel Aziz,Philip D. Mosier,Umesh R. Desai	22
13	9-Aminomethyl-9,10-dihydroanthracene (AMDA) analogs as structural probes for steric tolerance in 5-HT2A and H1 receptor binding sites 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),Philip D. Mosier,(unknown),Bryan L. Roth,Richard B. Westkaemper	7
14	Synthesis, structure–affinity relationships, and modeling of AMDA analogs at 5-HT2A and H1 receptors: Structural factors contributing to selectivity 2009 ·Bioorganic & Medicinal Chemistry ·(unknown),Philip D. Mosier,Bryan L. Roth,Glen E. Kellogg,Richard B. Westkaemper	20
15	A Structure-Affinity and Comparative Molecular Field Analysis of Sigma-2 (σ2) Receptor Ligands 2009 ·Central Nervous System Agents in Medicinal Chemistry ·Carmen Abate,Philip D. Mosier,Francesco Berardi,Richard A. Glennon	31
16	Tom1l2 hypomorphic mice exhibit increased incidence of infections and tumors and abnormal immunologic response 2008 ·Mammalian Genome ·Santhosh Girirajan,Paula M. Hauck,Stephen R. Williams,Christopher N. Vlangos,Barbara Szomju,(unknown),Philip D. Mosier,Kimber L. White,Kathleen L. McCoy,Sarah H. Elsea	18
17	Finding a Needle in a Haystack: Development of a Combinatorial Virtual Screening Approach for Identifying High Specificity Heparin/Heparan Sulfate Sequence(s) 2006 ·Journal of Medicinal Chemistry ·Arjun Raghuraman,Philip D. Mosier,Umesh R. Desai	64
18	Differential Helical Orientations among Related G Protein-coupled Receptors Provide a Novel Mechanism for Selectivity 2006 ·Journal of Biological Chemistry ·Timothy A. Vortherms,Philip D. Mosier,Richard B. Westkaemper,Bryan L. Roth	28
19	Discovery of imidazole glycerol phosphate dehydratase inhibitors through 3-D database searching 2002 ·Bioorganic & Medicinal Chemistry Letters ·Barbara A. Schweitzer,Paul J. Loida,Claire A. CaJacob,Robert Chott,(unknown),Shridhar G. Hegde,Philip D. Mosier,(unknown)	15
20	Prediction of Peptide Ion Collision Cross Sections from Topological Molecular Structure and Amino Acid Parameters 2002 ·Analytical Chemistry ·Philip D. Mosier,Anne E. Counterman,Peter C. Jurs,David E. Clemmer	38

About Philip D. Mosier

Philip D. Mosier is a scholar working on Cellular and Molecular Neuroscience, Cell Biology and Molecular Biology, having authored 48 papers that have together received 2.0k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (19 papers), Neuropeptides and Animal Physiology (13 papers) and Pharmacological Receptor Mechanisms and Effects (11 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (925 citations), Molecular Biology (1.5k citations) and Cell Biology (256 citations). Philip D. Mosier has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Bryan L. Roth, Umesh R. Desai, Richard B. Westkaemper, Eyal Vardy, Raymond C. Stevens, Vsevolod Katritch, Huixian Wu, Aaron A. Thompson, S. Wayne Mascarella and Daniel Wacker. Their work appears in journals such as Nature, Journal of Biological Chemistry and Angewandte Chemie International Edition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact